| 1 | Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection | Pai, M | McGill Univ/
Canada | 2014 | CLINICAL MICROBIO-LOGY REVIEWS | 568 | 综述 |
| 2 | Latent Mycobacterium tuberculosis Infection | Getahun, H | WHO/
Switzerland | 2015 | THE NEW ENGLAND JOURNAL OF MEDICINE | 485 | 综述 |
| 3 | Prevention of M-tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination | Hatherill, M | Univ Cape
Town/South
Africa | 2018 | THE NEW ENGLAND JOURNAL OF MEDICINE | 431 | 论著 |
| 4 | The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis | Menzies, D | Montreal
Chest Inst/
Canada | 2016 | LANCET INFECTIOUS DISEASES | 307 | 综述 |
| 5 | The global prevalence of latent tuberculosis: a systematic review and meta-analysis | Wejse, C | Aarhus Univ
Hosp/Denmark | 2019 | EUROPEAN RESPIRATORY JOURNAL | 264 | 综述 |
| 6 | Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis | Van Der
Meeren, O | Glaxo Smith
Kline/Belgium | 2019 | THE NEW ENGLAND JOURNAL OF MEDICINE | 263 | 论著 |
| 7 | Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults | Menzies, D | Montreal Chest
Inst/Canada | 2018 | THE NEW ENGLAND JOURNAL OF MEDICINE | 239 | 论著 |
| 8 | One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis | Chaisson, RE | Johns
Hopkins
Univ | 2019 | THE NEW ENGLAND JOURNAL OF MEDICINE | 196 | 论著 |